Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) Operating Margin: 17.42%

Is Hologic, Inc.’s operating margin high or low?

Hologic, Inc.'s operating margin of 17.42% is 36% below its 5-year average of 27.16%, near the low end of its 5-year range (16.58%–44.04%).

The operating margin for Hologic, Inc. (HOLX) is 17.42% as of Tuesday, June 9, 2026. It is below its 12-month average by 11.39% (19.66%).

HOLX Operating Margin Chart

HOLX Operating Margin
17.42%-20.46% 1Y
Zoom

HOLX Average Operating Margin Chart

HOLX Current vs Average Operating Margin Chart

HOLX Operating Margin Metrics

OPERATING MARGIN

17.42%

OPERATING MARGIN AVG TTM

19.66%

OPERATING MARGIN AVG 3Y

22.41%

OPERATING MARGIN AVG 5Y

27.16%

OPERATING MARGIN AVG 10Y

21.87%

OPERATING MARGIN AVG 15Y

15.37%

OPERATING MARGIN AVG 20Y

7.30%

CURRENT VS TTM AVG

-11.39%

CURRENT VS 3Y AVG

-22.26%

CURRENT VS 5Y AVG

-35.85%

CURRENT VS 10Y AVG

-20.33%

CURRENT VS 15Y AVG

+13.31%

CURRENT VS 20Y AVG

+138.74%

HOLX Competitors' Operating Margin

NAMEMARKET CAPOPERATING MARGINTTM3Y5Y
Hologic, Inc. (HOLX)17.42%19.66%22.41%27.16%
Moderna, Inc. (MRNA)$18.94B-158.13%-140.72%-73.36%-52.24%
Align Technology, Inc. (ALGN)$12.76B15.27%15.23%16.08%17.45%
BioNTech SE (BNTX)$21.87B-22.63%-35.20%5.18%14.03%
Mettler-Toledo International Inc. (MTD)$23.50B27.78%28.45%28.53%27.71%
Waters Corporation (WAT)$24.19B28.22%28.07%28.30%28.33%
Charles River Laboratories International, Inc. (CRL)$9.14B12.65%9.13%12.39%13.51%
Bio-Rad Laboratories, Inc. (BIO)$8.03B10.47%10.48%12.70%14.08%
Veeva Systems Inc. (VEEV)$27.37B28.68%26.93%23.33%24.40%
Hims & Hers Health, Inc. (HIMS)$6.46B4.50%4.35%-1.93%-10.04%

Operating Efficiency

Gross Margin

61.0%

Operating Margin

17.4%

Hologic, Inc. Operating Margin Formula & Definition

Operating Margin = Operating Income / Revenue

Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. Operating Margin FAQ

What is the operating margin for Hologic, Inc. (HOLX)?
The operating margin for HOLX stock is 17.42%.
Is Hologic, Inc.'s operating margin high or low?
Hologic, Inc.'s operating margin of 17.42% is 36% below its 5-year average of 27.16%, near the low end of its 5-year range (16.58%–44.04%).
What is the TTM average operating margin for Hologic, Inc. (HOLX)?
The TTM average operating margin for HOLX stock is 19.66%.
What is the 3Y average operating margin for Hologic, Inc. (HOLX)?
The 3Y average operating margin for HOLX stock is 22.41%.
What is the 5Y average operating margin for Hologic, Inc. (HOLX)?
The 5Y average operating margin for HOLX stock is 27.16%.
What is the 10Y average operating margin for Hologic, Inc. (HOLX)?
The 10Y average operating margin for HOLX stock is 21.87%.
What is the 15Y average operating margin for Hologic, Inc. (HOLX)?
The 15Y average operating margin for HOLX stock is 15.37%.
What is the 20Y average operating margin for Hologic, Inc. (HOLX)?
The 20Y average operating margin for HOLX stock is 7.30%.

Hologic, Inc. Operating Margin History

DATEOPERATING MARGIN
2025-09-2717.42%
2024-09-3021.90%
2023-09-3016.58%
2022-09-3033.73%
2021-09-3044.04%
2020-09-3029.26%
2019-09-303.99%
2018-09-30-7.39%
2017-09-3044.80%
2016-09-3019.37%
2015-09-3016.82%
2014-09-3011.05%
2013-09-30-36.36%
2012-09-305.68%
2011-09-3020.93%
2010-09-304.16%
2009-09-30-123.18%
2008-09-30-11.80%
2007-09-3020.01%
2006-09-3010.88%
2005-09-3011.34%
2004-09-305.50%
2003-09-301.48%
2002-09-301.13%
2001-09-30-10.54%
2000-09-30-29.18%
1999-09-30-11.41%
1998-09-309.34%
1997-09-3020.99%
1996-09-3013.72%

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini